Nicotine sensitization and analysis of brain-derived neurotrophic factor in adolescent β-arrestin-2 knockout mice

Synapse

Volumn 63, Issue 6, 2009, Pages 510-519

  Correll, Jennifer A ^a   Noel, Daniel M ^a   Sheppard, A Brianna ^a   Thompson, Kimberly N ^b   Li, Yi ^b   Yin, Deling ^b   Brown, Russell W ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b East Tennessee State University   (United States)

Author keywords

Adolescence; G protein; Mice; Nicotine; Nucleus accumbens; Psychostimulant

Indexed keywords

BETA ARRESTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HABITUATION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SENSITIZATION; TASK PERFORMANCE; WILD TYPE;

AGING; ANIMALS; ARRESTINS; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; NUCLEUS ACCUMBENS; UP-REGULATION;

EID: 66149086930     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20625     Document Type: Article

References (49)

1. Altar CA, Boylan CB, Jackson C, Hershenson S, Miller J, Wiegand SJ, Lindsay RM, Hyman C. 1992. Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo. Proc Natl Acad Sci USA 89:11347-11351.
2. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ. 1992. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267:17882-17890.
3. Balfour DJ. 2004. The neurobiology of tobacco dependence: A preclinical perspective on the role of the dopamine projections to the nucleus accumbens. Nicotine Tob Res 6:899-912.
4. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. 2005. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122:261-273.
5. Belluzzi JD, Lee AG, Oliff HS, Leslie FM. 2004. Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats. Psychopharmacology 174:389-395.
6. Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT. 1999. Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 24:2495-2498.
7. Bohn LM, Gainetdinov RR, Sotnikova TD, Medvedev IO, Lefkowitz RJ, Dykstra LA, Caron MG. 2003. Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci 23:10265-10273.
8. Bohn LM, Dykstra LA, Lefkowitz RJ, Caron MG, Barak LS. 2004. Relative opioid efficacy is determined by the complements of the G protein-coupled receptor desensitization machinery. Mol Pharmacol 66:106-112.
9. Britt JP, McGehee DS. 2008. Presynaptic opioid and nicotinic receptor modulation of dopamine overflow in the nucleus accumbens. J Neurosci 28:1672-1681.
10. Cadoni C, Di Chiara G. 2000. Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol 387:R23-R25.
11. Contet C, Kieffer BL, Befort K. 2004. Mu opioid receptor: A gateway to drug addiction. Curr Opin Neurobiol 14:370-378.
12. Corrigall WA, Coen KM. 1991. Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104:167-170.
13. Cruz FC, Delucia R, Planeta CS. 2005. Differential behavioral and neuroendocrine effects of repeated nicotine in adolescent and adult rats. Pharmacol Biochem Behav 80:411-418.
14. Daaka Y, Pitcher JA, Richardson M, Stoffel RH, Robishaw JD, Lefkowitz RJ. 1997. Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc Natl Acad Sci USA 94:2180-2185.
15. Faraday MM, Elliott BM, Grunberg NE. 2001. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol Biochem Behav 70:475-489.
16. Faraday MM, Elliott BM, Phillips JM, Grunberg NE. 2003. Adolescent and adult male rats differ in sensitivity to nicotine's activity effects. Pharmacol Biochem Behav 74:917-931.
17. Ferguson SS, Downey WE, 3rd, Colapietro AM, Barak LS, Menard L, Caron MG. 1996. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271:363-366.
18. Filip M, Faron-Górecka A, Kuśmider M, Gołda A, Frankowska M, Dziedzicka-Wasylewska M. 2006. Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res 1071:218-225.
19. French SJ, Humby T, Horner CH, Sofroniew MV, Rattray M. 1999. Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Brain Res Mol Brain Res 67:124-136.
20. Gainetdinov RR, Premont RT, Bohn LM, Lefkowitz RJ, Caron MG. 2004. Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci 27:107-144.
21. Greengard, P. 2001. The neurobiology of slow synaptic transmission. Science 294:1024-1030.
22. Grimm JW, Lu L, Hayashi T, Hope BT, Su TP, Shaham Y. 2003. Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: Implications for incubation of cocaine craving. J Neurosci 23:742-747.
23. Harrod SB, Mactutus CF, Bennett K, Hasselrot U, Wu G, Welch M, Booze RM. 2004. Sex differences and repeated intravenous nicotine: Behavioral sensitization and dopamine receptors. Pharmacol Biochem Behav 78:581-592.
24. Hatchell PC, Collins AC. 1980. The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology 71:45-49.
25. Horch HW. 2004. Local effects of BDNF on dendritic growth. Rev Neurosci 15:117-129.
26. Horger BA, Nishimura MC, Armanini MP, Wang L-C, Poulsen KT, Rosenbald C, Kirik D, Moffat B, Simmons L, Johnson E Jr, Milbrandt J, Posenthal A, Bjorklund A, Vandlen RA, Hynes MA, Phillips HS. 1998. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J Neurosci 18:4929-4937.
27. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR. 1999. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110-4122.
28. Jonnala RR, Terry AV Jr, Buccafusco JJ. 2002. Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sci 70:1543-1554.
29. Kalivas PW, Duffy P. 1993. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.
30. Kempsill FE, Pratt JA. 2000. Mecamylamine but not the alpha7 receptor antagonist alpha-bungarotoxin blocks sensitization to the locomotor stimulant effects of nicotine. Br J Pharmacol. 131:997-1003.
31. Kenny PJ, File SE, Rattray M. 2000. Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res Mol Brain Res 85:234-238.
32. Kieffer BL, Gavériaux-Ruff C. 2002. Exploring the opioid system by gene knockout. Prog Neurobiol 66:285-306.
33. Korsching S. 1993. The neurotrophic factor concept: A reexamination. J Neurosci 13:2739-2745.
34. Lefkowitz RJ, Shenoy SK. 2005. Transduction of receptor signals by beta-arrestins. Science 308:512-517.
35. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della-Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. 1999. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 283:655-661.
36. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, Lefkowitz RJ. 2001. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA 98:2449-2454.
37. Maggio R, Riva M, Vaglini F, Fornai F, Racagni G, Corsini GU. 1997. Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental Parkinsonism. J Neural Transm 104:1113-1123.
38. Maggio R, Riva M, Vaglini F, Fornai F, Molteni R, Armogida M, Racagni G, Corsini GU. 1998. Nicotine prevents experimental Parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem 71:2439-2446.
39. Marshall DL, Redfern PH, Wonnacott S. 1997. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: Comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519.
40. Martin-Iverson MT, Todd KG, Altar CA. 1994. Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: Interactions with amphetamine. J Neurosci 14:1262-1270. (Pubitemid 24081921)
41. Martínez-Rodríguez R, Toledano A, Alvarez MI, Turégano L, Colman O, Rosés P, Gómez de Segura I, De Miguel E. 2003. Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex. J Neurosci Res 73:708-716.
42. Meredith GE, Callen S, Scheuer DA. 2002. Brain-derived neurotrophic factor expression is increased in the rat amygdala, piriform cortex and hypothalamus following repeated amphetamine administration. Brain Res 949:218-227.
43. Miller DK, Wilkins LH, Bardo MT, Crooks PA, Dwoskin LP. 2001. Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism. Psychopharmacology 156:469-476.
44. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. 1998. Dopamine receptors: From structure to function. Physiol Rev 78:189-225.
45. Nair VD, Sealfon SC. 2003. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor. J Biol Chem 278:47053-47061.
46. Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T. 2003. Implication of brain-derived neurotrophic factor in the release of dopamine and dopamine-related behaviors induced by methamphetamine. Neuroscience 119:767-775.
47. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS. 2000. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 275:17201-17210.
48. Pierce RC, Kalivas PW. 1997. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Brain Res Rev 25:192-216.
49. Pierce RC, Pierce-Bancroft AF, Prasad BM. 1999. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen-activated protein kinase signal transduction cascade. J Neurosci 19:8685-8695.